The Accidental System

The System That Wasn’t Designed

In October 1942, with American industrial production reorganized for the war effort and the labor market under federal wage and price controls, the National War Labor Board faced a problem that had no precedent in American labor relations.¹ Employers, prohibited by the wage stabilization order from raising cash wages to attract scarce wartime labor, were experimenting with non-cash benefits — pension contributions, paid vacation, and, in a small but growing number of cases, employer-paid health insurance. The Board’s General Order Number 16, issued October 27, 1942, ruled that such “fringe benefits” were exempt from the wage cap, provided they did not exceed a reasonable share of total compensation. The ruling was a wartime expedient. Its long-term consequences were not contemplated.

The decisive accident occurred on October 26, 1943, when the Internal Revenue Service issued a private letter ruling — later codified — holding that employer contributions to group health insurance plans were not taxable income to the employee.² The ruling treated employer-paid premiums as a business expense for the employer and as a non-taxable benefit for the employee. The combined treatment produced an effective subsidy: a dollar of cash wages cost the worker income tax (and, after 1937, payroll tax) plus cost the employer payroll tax; a dollar of employer-paid health insurance cost neither party any tax at all. By 1944, the differential was substantial; by 1954, when the Internal Revenue Code was comprehensively revised under President Eisenhower and the exclusion was formally written into Section 106, it had become structural. The American workforce, by the early 1950s, was being taught by the tax code to receive health insurance through the employer.

The system that resulted was an artifact of wartime expediency, IRS administrative interpretation, and the post-war legislative coincidence that codified both. It was not the system any reform-minded American policymaker had proposed. President Roosevelt had wanted national health insurance and had postponed the proposal for the war. President Truman, taking up the proposal in November 1945, made universal health insurance the principal domestic policy initiative of his second term.³ The Wagner-Murray-Dingell Bill, introduced repeatedly between 1943 and 1949, would have established a national health insurance program funded through Social Security payroll contributions, available to all Americans, with the federal government as the single buyer of medical services. The American Medical Association, in the most expensive lobbying campaign that had been mounted against any single piece of legislation up to that date, defeated it.⁴ The AMA’s 1948 campaign, organized by the Whitaker & Baxter public relations firm at a cost of roughly four and a half million dollars (approximately sixty million in 2025 dollars), framed national health insurance as “socialized medicine” — a phrase coined for the campaign — and produced what is now considered the foundational template of post-war American interest-group politics. The Truman bill failed. The structural alternative — the employer-tied insurance system the IRS rulings had created — became, by default, the operative American framework.

The default framework expanded across the 1950s and 1960s through the spread of employer health benefits to the unionized industrial workforce, the salaried professional classes, and, eventually, much of the broader employed population. Medicare and Medicaid, enacted in 1965 under President Johnson as Title XVIII and Title XIX of the Social Security Act, addressed the principal populations the employer-tied system structurally excluded — the elderly, the disabled, and the indigent.⁵ The Medicare/Medicaid additions did not replace the employer system; they added two new federal buyers alongside the multiple employer-purchased plans, the Blue Cross/Blue Shield insurer-of-last-resort networks, the still-developing commercial insurance industry, and the still-uninsured. The effect was to fragment the buyer side further. By 1970, the American healthcare system had four distinct categories of payer (employer-purchased plans, Medicare, Medicaid, and the uninsured paying out of pocket), each operating under different rules, each negotiating different prices with the same hospitals and physicians, each producing different administrative-overhead structures.

The 1973 Health Maintenance Organization Act, signed by President Nixon, added a fifth structural category: the integrated insurer-provider organization, designed to control costs through prospective payment and capitated risk-bearing.⁶ The 1974 Employee Retirement Income Security Act (ERISA) preempted state-level regulation of self-funded employer health plans, removing them from the state insurance regulatory framework that applied to fully-insured employer plans.⁷ By 1980, the American healthcare system had six structurally distinct categories of payer (employer-purchased fully-insured plans, employer-purchased self-funded plans, Medicare, Medicaid, HMO arrangements, and the uninsured), each negotiating separately, each with different price schedules for the same services. No comparable developed country had constructed anything resembling this structure. It had not been designed; it had accumulated.

The Clinton administration, in 1993, attempted what the Truman administration had failed to attempt and what every developed country except the United States had eventually accomplished: a comprehensive restructuring of the healthcare system into a single coherent framework.⁸ The Health Security Act, drafted by a task force chaired by Hillary Rodham Clinton, would have created universal coverage through a system of regional health alliances, employer mandates, and managed competition. The bill collapsed in committee in September 1994 without reaching a floor vote in either chamber. The structural alternative the task force had proposed — managed competition within a universal-coverage framework — never reached the operative American debate again. The Affordable Care Act of 2010, the most consequential healthcare legislation since Medicare, did not propose to restructure the underlying buyer-side fragmentation; it added a seventh structural category (the regulated individual marketplaces, the federal subsidy mechanism for them, and the Medicaid expansion to a broader population), and constrained insurer practices through new rules.⁹ The seven categories of payer that emerged from the ACA-era system are the categories the United States operates under today.

The system is, by every available comparative measure, the most expensive in the developed world and produces outcomes that, on most measures, are not the best.¹⁰ The next sections describe what the structure produces, what both major parties have done about it, and why the fourth-settlement reform sketched in the previous essays in this series has, in this case, been particularly difficult to assemble.

The Fragmented Buyer

The structural problem of American healthcare can be stated in a single sentence. The buyer side is fragmented across seven structurally distinct categories, none of which has the market power to negotiate prices comparable to those negotiated by the unified single-buyer systems of every other developed country, while the seller side has consolidated to a degree that, in many local markets, leaves no competitive alternative. The buyer-seller asymmetry is not principally a matter of cultural preference for “competition” or of ideological commitment to “market choice”; it is the operational outcome of the historical accumulation described in the previous section. The asymmetry produces prices.

Hospital prices are the most-studied case, and the empirical record is extensive. The 2019 Health Care Cost Institute and Yale School of Public Health analyses of employer-sponsored insurance claims, drawn from approximately fifty million covered lives across the four largest national insurers, found that hospital prices for the same procedures vary by factors of three to ten across hospitals within the same metropolitan area, and that the variation correlates strongly with hospital market concentration.¹¹ In the most-concentrated metropolitan hospital markets — the markets where one or two hospital systems control the majority of beds — average commercial prices were two to three times Medicare rates for comparable procedures. In the least-concentrated markets, the multiple was approximately one and a half times. The Federal Trade Commission and the American Hospital Association have contested the interpretation; the FTC’s hospital merger litigation across the 2010s has generally followed the price-concentration finding.¹² The price differential between commercial insurance and Medicare is approximately the differential between fragmented-buyer and consolidated-buyer market power. Medicare, as the single largest payer in most local markets, can set rates; the fragmented commercial buyers cannot.

Pharmaceutical prices follow the same logic at a different scale. The American pharmaceutical pricing system is structurally distinct from every comparator system because Medicare, by statutory exclusion in the 2003 Medicare Modernization Act, is barred from negotiating prices with manufacturers.¹³ The exclusion was a deliberate concession to the pharmaceutical industry in exchange for industry support of the Medicare Part D prescription drug benefit. Its consequence is that the largest American buyer of pharmaceuticals operates as a price-taker rather than a price-setter. The fragmented commercial insurers, the Veterans Affairs system (which is permitted to negotiate and does, achieving prices roughly forty percent below Medicare’s), and the foreign national health systems (which negotiate prices roughly fifty to seventy percent below American commercial prices) demonstrate that the absence of negotiation is the structural feature producing the price differential.¹⁴ The Inflation Reduction Act of 2022 partially repealed the Medicare negotiation exclusion for a small number of high-cost drugs, with the first negotiated prices taking effect in 2026.¹⁵ The structural pattern, however, remains: American pharmaceutical prices are set by a market in which the largest buyer is statutorily barred from exercising negotiating power.

Insurance company concentration adds a third layer. The four largest commercial health insurers — UnitedHealth, Anthem (now Elevance Health), Aetna (now part of CVS Health), and Cigna — control approximately sixty percent of the commercial insurance market, with substantially higher concentration in many state-level markets.¹⁶ The American Hospital Association’s 2024 analysis of state-level insurance market concentration found that, in approximately three-quarters of metropolitan statistical areas, two insurers controlled more than half of the commercial market. The insurance side’s consolidation does not produce the lower prices that buyer concentration in a single-buyer system would; it produces, in combination with the consolidated provider side, a bilateral oligopoly in which prices are set through negotiation between concentrated sellers and concentrated buyers, with the household — the eventual payer — absorbing the prices the negotiation produces.

The administrative overhead of the fragmented system is the second consequence of the structure, and it is the consequence the comparative literature has documented most thoroughly. Steffie Woolhandler and David Himmelstein, in a 2003 New England Journal of Medicine article that has been replicated repeatedly, found that administrative costs in the American healthcare system consume approximately thirty percent of healthcare spending, compared with approximately seventeen percent in Canada and similar single-payer or unified-multi-payer systems.¹⁷ The thirteen-percentage-point differential, applied to American healthcare spending of approximately four and a half trillion dollars in 2024, represents approximately five hundred billion dollars annually — roughly half of the federal Medicare budget — consumed in claim adjudication, prior authorization, billing, coding, denial appeals, network maintenance, formulary management, and the parallel administrative apparatus that the seven-category buyer structure requires. The five hundred billion dollars is not principally consumed by waste or fraud. It is consumed by the administrative coordination cost of operating seven structurally distinct buyer systems negotiating with a consolidated provider system through a fragmented insurance intermediary system. The cost is structural; it is not reducible without restructuring.

The combination — high prices, high administrative overhead, and the absence of a unified buyer capable of constraining either — produces the per-capita spending differential that is the most-cited single statistic in American healthcare comparative analysis. The United States spends approximately eighteen percent of GDP on healthcare, against an OECD average of approximately ten percent, and produces, on most population-health measures, outcomes ranging from comparable to substantially worse than the comparator nations.¹⁸ The eight-percentage-point GDP differential, applied to a twenty-seven-trillion-dollar economy, represents approximately two trillion dollars annually that the American healthcare system spends in excess of what it would spend if it operated at the cost level of the median OECD country. The two trillion dollars is the price the American household pays — directly through premiums, copays, and deductibles, indirectly through suppressed wages, indirectly through Medicare and Medicaid taxation that flows back through the same overpriced provider system — for the buyer-side fragmentation that the historical accident described in the previous section produced.

The Bill That Follows

The previous section described the system at the macroeconomic scale. This section describes what the system produces at the household scale, which is where the structural cost is paid.

The medical-bankruptcy literature, principally the work of David Himmelstein, Elizabeth Warren, Steffie Woolhandler, and Deborah Thorne, has documented the relationship between American healthcare costs and household financial collapse across two decades of consistent research.¹⁹ The headline finding, drawn from the 2007 study published in Health Affairs and replicated in subsequent analyses, is that approximately sixty to sixty-five percent of American personal bankruptcies in the studied period were “medically related” — that is, were filed by households reporting that medical bills, medical-debt-related income loss, or both, were a substantial cause of the bankruptcy. Subsequent critiques narrowed the share that could be attributed primarily to medical causes; the most cited revision, by economists Carlos Dobkin, Amy Finkelstein, Raymond Kluender, and Matthew Notowidigdo in 2018, found that approximately four percent of bankruptcies in their sample of older adults were attributable specifically to a hospital admission, with the broader category of medically-related bankruptcies remaining substantially larger.²⁰ The methodological dispute is real and is unresolved. What is not in dispute is that the United States is the only developed country in which the medical-bankruptcy category exists at the scale it does. The category is not present in the bankruptcy literatures of Canada, the United Kingdom, Germany, France, the Netherlands, Japan, Australia, or any other comparator nation. The mechanism that produces it does not operate in those countries because the buyer-side fragmentation that produces the underlying cost structure does not exist there.

The mechanism by which the cost structure produces household financial collapse, in the American case, can be described in three steps that are independent of the macroeconomic critique above. The first step is the deductible. Employer-sponsored health insurance plans in the United States have shifted, across the 2010-2024 period, from a model in which the insurance covered most costs after a small deductible (typical 2010 deductible: approximately three hundred dollars for individual coverage) to a model in which the insurance covers costs only after a substantially larger deductible (typical 2024 deductible: approximately one thousand seven hundred dollars for individual coverage, with high-deductible plans approaching three thousand dollars).²¹ The shift has been pronounced for small-employer coverage and for the marketplace plans the ACA established. The structural effect is that, for any medical event whose cost falls below the deductible — which includes most outpatient care, most prescription costs, and a substantial portion of routine inpatient care — the insured household pays the full negotiated price, after the insurance has done its negotiation work but before the insurance pays anything.

The second step is the coinsurance. After the deductible is met, most contemporary American health insurance plans require the insured to pay a percentage (typically twenty to thirty percent) of further covered costs up to the annual out-of-pocket maximum. The out-of-pocket maximum is statutorily capped under the ACA at, in 2024, nine thousand four hundred fifty dollars for individual coverage and nineteen thousand one hundred dollars for family coverage, before the insurance assumes full responsibility.²² The combination — deductible plus coinsurance up to out-of-pocket max — means that an insured American household facing a serious medical event can be exposed to between approximately ten thousand and twenty thousand dollars in covered medical expense before insurance pays the full remainder, and additional sums for any uncovered or out-of-network care. For the approximately forty percent of American households that, by Federal Reserve survey data, cannot cover a four-hundred-dollar emergency expense from savings, the deductible-plus-coinsurance exposure is structurally beyond the household’s ability to absorb without taking on debt.²³

The third step is the out-of-network exposure. Even after the ACA’s network-adequacy requirements and the No Surprises Act of 2020, American patients continue to receive bills from providers — particularly emergency-department physicians, anesthesiologists, and pathologists — whose services are not covered under their plan’s network agreement, and whose billed charges substantially exceed the plan’s allowable amounts.²⁴ The 2020 surprise-billing legislation addressed the most egregious category (emergency-department services and certain ancillary providers at in-network facilities), but the underlying mechanism — that the patient is billed by parties she did not choose, at prices she could not anticipate, in a transaction whose terms she had no opportunity to negotiate — remains operative across substantial categories of American healthcare delivery. The patient who receives an out-of-network bill after the fact has limited recourse beyond payment, dispute, or default; default produces the medical debt that is then sold to collection agencies and that, by the Consumer Financial Protection Bureau’s analysis, represents approximately fifty-eight percent of all collections accounts on American consumer credit reports.²⁵

The combined mechanism produces the household-extraction structure that distinguishes American healthcare from every comparator system. The household pays the insurance premium (annual cost: approximately ten thousand five hundred dollars for family employer coverage in 2024, of which the employer pays roughly seventy percent and the household pays roughly thirty percent through payroll deduction).²⁶ The household pays the deductible. The household pays the coinsurance. The household pays the out-of-network bills. The household pays, indirectly, through the suppressed wages that are the inevitable counterpart of the employer’s seventy-percent share of the premium. The household pays, through Medicare and Medicaid taxation, the fragmented federal-system costs that flow back through the same overpriced provider system. The cumulative household expense of the American healthcare system is approximately fifteen to twenty thousand dollars per year for a typical employer-insured family, with substantially higher exposure in any year in which a serious medical event occurs.²⁷ The exposure to the variable component is what distinguishes the American system from the comparator systems. In every other developed country, the variable component is bounded by a national-system out-of-pocket cap that operates as a true cap, not as a deductible-plus-coinsurance escalator that rises with the underlying cost structure.

The system, in operational terms, is a household-extraction mechanism whose extraction rate rises with the household’s contact with the medical system. The healthier the household, the lower the extraction. The sicker the household, the higher the extraction. The relationship is the inverse of what an insurance system, classically understood, is supposed to produce.

The Two Parties’ Two Failures

The structural inadequacy of the American healthcare system is, across the empirical literature and across the comparative record, well-established. Both major political parties have, over the past forty years, advanced reform proposals. The reform proposals have not addressed the structural problem. The reasons each party’s proposals have not addressed the structural problem are different, and require different analyses.

The Democratic position, as it has developed across the Clinton-Obama-Biden period, has been incremental expansion of the existing fragmented structure rather than restructuring of the structure itself. The Affordable Care Act of 2010, the most consequential Democratic healthcare initiative since Medicare, added a seventh category of payer (the regulated individual marketplaces) and a federal subsidy mechanism for that category, expanded the Medicaid category to a broader income range, and constrained insurer practices through new rules on coverage, underwriting, and medical loss ratios.²⁸ The ACA did not address the buyer-side fragmentation at the structural level; it added a category. The ACA did not address the price-negotiation asymmetry; it preserved the existing system in which Medicare and Medicaid negotiate but the commercial side does not. The ACA did not address the employer-tied insurance system; it preserved the WWII-era tax exclusion and added an employer mandate that reinforced the structure. The ACA’s empirical achievement was substantial: approximately twenty million additional Americans gained coverage, the uninsured rate fell from approximately sixteen percent (2010) to approximately eight percent (2024), and the insurer-practice reforms (guaranteed issue, community rating, essential health benefits, dependent coverage to age twenty-six) produced documented improvements in coverage adequacy.²⁹ The ACA’s structural commitments, however, were to preservation rather than restructuring of the system the previous sections described. The buyer-side fragmentation continued. The prices continued. The medical-bankruptcy mechanism continued, at modestly attenuated scale.

The Medicare for All proposal that has been advanced within the Democratic coalition, principally by Senator Bernie Sanders and Representative Pramila Jayapal, would address the structural problem through unification: a single federal buyer, replacing the seven existing categories, negotiating prices with providers and pharmaceutical manufacturers on behalf of the entire American population.³⁰ The proposal has been the subject of repeated legislative introductions across the 2017-2024 period and has not advanced beyond committee in either chamber. The reason for the non-advance, in the principal Democratic-coalition critique, is political rather than structural: the proposal would require eliminating the employer-sponsored insurance system on which roughly half of the American workforce currently depends, and the political cost of that elimination has been judged by Democratic congressional leadership to be greater than the political coalition currently available to support it. The judgment has been reinforced by the empirical record of state-level single-payer initiatives — Vermont’s 2014 abandonment of its Green Mountain Care plan, California’s repeated failed attempts — which have demonstrated the difficulty of constructing the financing structure even at the state scale.³¹

The structural Democratic position, then, is that the system requires substantial reform; that the reform that would address the structural problem (single-payer) is politically out of reach; and that the reform that is politically available (incremental ACA expansion) does not address the structural problem. The position is internally coherent and has produced the policy record described above. It does not, on its current trajectory, produce a path to the system the comparative record indicates would address the underlying cost and bankruptcy mechanisms.

The Republican position has been structurally different and has produced a different pattern of failure. The Republican coalition’s principal healthcare framework, articulated across the 1980-2024 period, has been that the American healthcare cost problem is a function of insufficient market competition and of regulatory burden, and that the appropriate response is reduction of regulation, expansion of consumer-directed mechanisms (Health Savings Accounts, high-deductible plans), and devolution of federal authority to the states (block-grant Medicaid).³² The framework has been the policy basis of the Republican alternatives offered to the ACA across the post-2010 period, including the American Health Care Act and the Better Care Reconciliation Act of 2017, both of which would have substantially reduced federal Medicaid spending, eliminated the insurance subsidies, and weakened the insurer-practice constraints. The 2017 reform attempts failed in the Senate by narrow margins and have not been re-attempted at scale.

The empirical problem with the Republican framework is that the contemporary American healthcare market is not under-competitive in the conventional consumer-product sense; it is structurally non-competitive at the level of buyer-seller market power, in the manner the previous sections described. Increasing consumer-directed cost exposure does not produce lower prices in a market where the seller side has consolidated faster than the buyer side and where the buyer (the patient) has substantially less information about the value of available alternatives than the seller (the hospital, the physician, the pharmaceutical manufacturer). The economic literature on consumer-directed healthcare, across roughly twenty years of empirical research, has consistently found that high-deductible plans reduce healthcare consumption — including consumption of high-value preventive and chronic-disease management care — without producing the price-discipline effects the framework predicts.³³ The framework is empirically refuted at the scale at which it has been tested, which is now substantial. The Republican coalition has not articulated a structurally different alternative.

Both parties’ positions share one operational commitment, which is the central feature of the American healthcare system that the comparative record indicates is the principal structural barrier to comprehensive reform: the preservation of the employer-tied insurance system. The Democratic coalition’s stakeholders — labor unions whose collectively-bargained health plans are a substantial portion of the negotiated compensation package, employer-coalition lobbying that prefers the structural status quo to either single-payer or restructured-marketplace alternatives, the insurance industry that derives substantial profit from administering employer-purchased plans — do not support eliminating the employer system. The Republican coalition’s stakeholders — the same insurance industry, the same employer coalitions, the constituencies that benefit from the WWII-era tax exclusion which is, by Joint Committee on Taxation scoring, the single largest “tax expenditure” in the federal budget at approximately two hundred and seventy billion dollars annually — do not support eliminating the employer system either.³⁴ Both parties’ coalitions are operationally invested in preserving the structural feature that the comparative record indicates is the principal source of the system’s malfunction.

The result is the impasse that has now extended for fifteen years since the ACA, for thirty years since the Clinton task force, for sixty years since Medicare, for eighty years since the Truman bill. The system continues to operate in the form the historical accident of 1943-1954 produced. The reforms that would address the structural problem are politically out of reach. The reforms that are politically available do not address the structural problem.

The Policy That Won’t Come

The Intelligent Party’s policy proposal on healthcare, articulated in the platform’s health position, is a structural alternative that neither major party has advanced and that, in its specific architecture, addresses the buyer-side fragmentation problem the previous sections diagnosed.³⁵ The proposal has four components, each of which addresses one of the structural features the previous sections identified.

The first component is universal catastrophic coverage as a federally-funded floor. Every American, regardless of employment status, age, or income, would be enrolled in a federal catastrophic plan with an out-of-pocket maximum tied to household income (a graduated cap that would, for example, prevent any American household from medical out-of-pocket exposure exceeding a defined percentage of income). The plan would cover hospitalization, emergency care, and the categories of medical event whose cost magnitude is the principal driver of medical bankruptcy. The plan would not cover routine outpatient care, prescription medications outside catastrophic categories, or elective procedures.

The second component preserves market choice above the floor. Households that wish to maintain private insurance for the categories of care the catastrophic plan does not cover, or that wish to maintain Health Savings Accounts for routine and elective care, may continue to do so under existing tax treatment. Employer-sponsored insurance continues to exist as a category but, over a fifteen-year transition, loses its preferential tax treatment. The decoupling of insurance from employment is gradual rather than abrupt, allowing the labor market to adjust without the labor-market disruption that immediate single-payer transitions have been judged to produce.

The third component extends Medicare-style price negotiation across all payers. Hospital and pharmaceutical prices, which are currently negotiated by Medicare and Medicaid but not by the commercial buyer side, become subject to a federal negotiating authority that operates on behalf of all payers. The structural asymmetry between fragmented commercial buyers and consolidated sellers is addressed by giving the buyer side, in aggregate, the negotiating power of the largest single buyer. The mechanism does not eliminate private insurance; it eliminates the price differential between insurance categories that the current fragmentation produces.

The fourth component is a public option available in every individual marketplace, structured as Medicare buy-in for those who prefer the public alternative. The public option does not displace private insurance; it provides a parallel choice that constrains private-insurer pricing through competition, and that scales the federal buyer-side negotiating power gradually as more Americans choose to participate.

The four components, taken together, address the structural problem the previous sections identified without requiring the political coalition that single-payer requires. The catastrophic floor eliminates medical bankruptcy. The cross-payer price negotiation addresses the buyer-seller asymmetry. The fifteen-year decoupling of employer insurance allows the labor market to absorb the structural transition without the disruption an immediate transition would produce. The public option provides the parallel choice that constrains the private side. Each component has been advanced, in some form, by mainstream policy analysts; the assembly of the four into a coherent framework is novel; the coherent framework has not been advanced by either major party.

The reasons for the non-advance are the reasons that have prevented every comprehensive American healthcare reform since 1948. The political coalition that would benefit from the framework — the substantial majority of American households that the current system extracts from at every contact with the medical system — has not assembled into a political force capable of overcoming the lobbying power of the insurance industry, the pharmaceutical industry, the hospital industry, and the employer coalitions whose structural interests the current system serves. The lobbying power was described in the previous essay in this series.³⁶ The mechanism by which the lobbying power blocks comprehensive reform is the dependence-corruption mechanism that Lessig diagnosed: not principally the buying of specific votes but the structural shaping of which proposals are drafted, which compromises survive markup, which alternatives reach the Senate floor. The American healthcare system continues to operate in the form the historical accident produced, not because the structural alternatives are technically infeasible — every comparator system operates with a different structure successfully — but because the political-economy lock-in described in The Donor Class prevents the alternatives from being enacted.

The Cascade That Closes

The healthcare cost mechanism described in the previous sections, viewed in isolation, is a chronic structural inefficiency that the American economy has absorbed for decades. Viewed in combination with the AI labor cascade and the housing carrying-cost cascade described in the previous essays in this series, the mechanism becomes the third axis of household extraction whose collision with the other two defines the structural conditions of the next decade.

The AI Implosion described the wage cascade: the compression of knowledge-work wages that, on the trajectory described, will reduce the income against which any household expense — housing carrying cost, healthcare carrying cost, debt service — must be paid.³⁷ The Quiet Foreclosure described the housing carrying-cost cascade: the property-tax and insurance escalation that, against compressing income, produces the forced-sale mechanism by which paid-off owner-occupiers lose homes.³⁸ The healthcare extraction mechanism described in the present essay produces a third compression on the same household: the rising premium share, the rising deductible exposure, the rising out-of-pocket variability that, against compressing income, produces the medical-debt and medical-bankruptcy outcomes the previous sections documented.

The three compressions interact in ways that the household-finance literature is only beginning to model. The household experiencing AI-driven wage compression, against rising housing carrying costs, against rising healthcare carrying costs, faces a structural budget problem that the conventional household-finance frameworks do not capture. Each individual extraction is, considered alone, a manageable shock; the household can absorb a wage compression of ten percent, a property-tax increase of forty percent, or a medical event of fifteen thousand dollars. The household cannot absorb all three simultaneously, in a five-year window, against an income that is also compressing. The combined shock exceeds the absorption capacity. The household responds by depleting savings, by taking on consumer debt, by tapping retirement accounts, by selling the home, by filing bankruptcy, by some combination of the above. The empirical record of household responses to this kind of multi-axis shock is the empirical record of the post-2020 American household, which has been extensively documented in the consumer credit, household debt, and bankruptcy literatures since 2022.

The medical-bankruptcy mechanism is, in this combination, the principal accelerator. The household that is absorbing wage compression and rising housing costs has a savings buffer that is, by Federal Reserve data, structurally inadequate.³⁹ The medical event that exhausts the buffer — the cancer diagnosis, the cardiac event, the orthopedic injury, the maternity care that exceeds insurance coverage — produces the cascade that the prior absorption had been preventing. The medical debt is the trigger; the wage compression and the housing costs are the conditions. The bankruptcy that follows is medically caused, in the colloquial sense, but is structurally produced by the combination of all three.

The forecast the combination supports is that medical bankruptcies, which have been at historically elevated levels through the post-2020 period, will rise further in the next five years as the AI cascade compresses the wage base and the housing carrying-cost cascade depletes the savings buffers. The forced sales the bankruptcy produces will move the affected households into the rental market at prices the institutional buyer class — the same class The Quiet Foreclosure identified — has positioned to capture. The wealth that took thirty years to accumulate transfers, in the medical-event-precipitated sale, to the institutional buyer of the foreclosed or distressed-sale home. The medical event is the proximate cause; the structural cause is the combination of three extraction mechanisms operating simultaneously against a household whose income, in the AI-cascade environment, is no longer growing.

The political-economy consequences of this projection are the consequences the previous essays have collectively described. The constituency facing the combined cascade is the constituency that, on the historical record, has not assembled into a political force capable of producing the structural reforms that would arrest it. The structural reforms are blocked by the donor-class lock-in described in The Donor Class. The donor class is overwhelmingly composed of the beneficiaries of the same extraction mechanisms — the institutional landlords who acquire the distressed properties, the pharmaceutical and hospital industries whose pricing the fragmented buyer side fails to constrain, the insurance industry whose administrative apparatus the fragmented system requires, the AI-economy capital owners whose returns the wage cascade is producing. The same population benefits from each axis of the cascade. The same population funds the political coalitions that prevent reform of any of them.

The fourth-settlement framework the previous essays have sketched, applied to healthcare, is the four-component proposal the previous section described. The political coalition required to enact it does not currently exist. The conditions under which it might assemble are the conditions the multi-axis cascade is now producing. The next decade will determine whether the assembly occurs in time to constrain the cascade or whether the cascade runs its course before the political response arrives.

What’s at Stake

The American political economy has confronted the question of universal healthcare four times before, and three of the four times the question was answered in the negative.

The first attempt, under President Truman in 1945-1948, would have established a national health insurance program funded through Social Security payroll contributions and would have created the unified-buyer system every other developed country eventually adopted in some form. The attempt failed against the AMA’s “socialized medicine” campaign and the structural inertia of the WWII-era tax exclusion. The default that emerged — the employer-tied insurance system — became the operative American framework.

The second attempt, under President Johnson in 1965, succeeded for two specific populations (the elderly and the indigent) and established Medicare and Medicaid as substantial federal commitments. The attempt did not extend universal coverage to the working-age population; the default for that population remained the employer-tied system the IRS rulings had established.

The third attempt, under President Clinton in 1993-1994, would have established universal coverage through a managed-competition framework with regional health alliances and an employer mandate. The attempt failed in the legislative process without reaching a floor vote in either chamber.

The fourth attempt, under President Obama in 2009-2010, produced the Affordable Care Act. The Act extended insurance to approximately twenty million additional Americans, constrained insurer practices in ways that produced documented coverage improvements, and added a seventh category of payer to the existing fragmented structure. The Act did not address the buyer-side fragmentation, the price-negotiation asymmetry, or the employer-tied insurance system. The Act preserved, in their operative form, the structural features that the historical accident of 1943-1954 had produced.

A fifth attempt is now required, and it is structurally different from the four that preceded it. The Truman attempt would have replaced the system before it had fully formed. The Johnson attempt added two federal programs to the system without replacing it. The Clinton attempt would have restructured the system in place. The Obama attempt added one more category to the system without restructuring it. The fifth attempt, on the policy framework The Intelligent Party has proposed, would address the structural feature — the buyer-side fragmentation — through the cross-payer price-negotiation authority, while preserving the political feasibility — the gradual rather than abrupt transition — through the fifteen-year decoupling timeline. The framework’s components are not novel individually; the assembly is novel; the political coalition required to enact the assembly does not currently exist.

The conditions under which the coalition might assemble are the conditions the previous essays in this series have described. The donor-class lock-in described in The Donor Class is the principal obstacle to the assembly. The conditions under which the lock-in itself might break — the structural break in the political-economy equilibrium that the AI labor cascade and the housing carrying-cost cascade are producing — are the conditions under which the healthcare reform also becomes available. The fifth attempt at universal healthcare, on the trajectory the series has described, is not principally a healthcare-policy question. It is a question about whether the political-economy lock-in that has prevented every major American structural reform since the 1970s will break before the cascades it has prevented from being addressed run their course.

The comparative record is, in this case as in the others, instructive. Every other developed country has built some version of the unified-buyer system that the American Truman attempt would have built. None of those systems is identical; the United Kingdom’s NHS, the German Sickness-Fund system, the French Sécurité Sociale, the Canadian provincial single-payer, the Dutch regulated-insurance system, the Australian Medicare are each structurally distinct from one another. They share the feature that the American system lacks: a unified-buyer mechanism that constrains seller-side pricing and that prevents the medical-event household-bankruptcy outcome. None of those countries spends more than approximately eleven percent of GDP on healthcare. None of those countries produces the medical-bankruptcy outcomes the American system produces at scale. The comparative record demonstrates, with substantial empirical support, that the structural reform is feasible. The American failure to enact it is not principally a matter of feasibility. It is a matter of political-economy lock-in.

The realism the previous essays have called for, applied to healthcare, is the realism that the structural reform is achievable on the specific architecture The Intelligent Party has proposed; that the architecture has been designed to address the political feasibility constraints that have prevented the more ambitious single-payer alternatives; that the principal obstacle to its enactment is the donor-class lock-in that operates against every fourth-settlement reform; and that the conditions under which the lock-in breaks are the conditions under which all of the fourth-settlement reforms simultaneously become available. The healthcare reform is one component of a larger settlement. It cannot, on the trajectory the series has described, be enacted in isolation. It will, when the assembly that the next decade may produce assembles, be enacted alongside the housing reform, the AI-labor reform, and the campaign finance reform that the previous essays have described.

The essay about the American healthcare system that someone writes in 2040 will describe either the construction of that fifth-attempt settlement or its refusal. The constituency that would benefit from the settlement is the constituency the four prior failed attempts have not assembled. The constituency exists; it is the great majority of American households whose healthcare costs have, across the five decades since the failure of the Truman bill, risen at rates substantially exceeding the rates the comparator nations have experienced. Its political assembly has not yet occurred. The structural conditions for the assembly, on the trajectory the previous essays have described, will be in place within the next decade.

Truman, in his 1948 message to Congress that re-introduced the Wagner-Murray-Dingell legislation he had inherited from the Roosevelt administration, said that “the health of our people is the foundation of our national strength, and the cost of medical care should be a matter of legitimate national concern.”⁴⁰ The sentence is the foundational statement of the American case for universal healthcare; it has been quoted in every subsequent serious reform attempt; it remains, after seventy-eight years, an operative diagnosis of the American system. The framework Truman called for has not been built. The framework is still buildable. The question the next decade will answer is whether the constituency that would build it can assemble, against the lock-in that has prevented its assembly across four failed attempts, in time to constrain the cascade the previous essays have described.

The accidental system was not the system anyone designed. The system that replaces it will have to be designed deliberately. The political moment for the deliberate design is, on the trajectory of the broader settlement the series has described, approaching.

---

Notes